Skip to main content
PMC home page
Gut logoLink to Gut
. 1991 Sep;32(Suppl):S73–S78. doi: 10.1136/gut.32.suppl.s73

Primary biliary cirrhosis.

J Neuberger 1, M Lombard 1, R Galbraith 1
PMCID: PMC1405232  PMID: 1916473

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Aghbar M. N., Alexander G. J., Nouri-Aria K. T., Neuberger J., Eddleston A. L., Williams R. In vitro effect of cyclosporin A on immunoglobulin production and concanavalin A induced suppression in primary biliary cirrhosis. Gut. 1986 Mar;27(3):317–323. doi: 10.1136/gut.27.3.317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amoroso P., Vergani D., Wojcicka B. M., McFarlane I. G., Eddleston A. L., Tee D. E., Williams R. Identification of biliary antigens in circulating immune complexes in primary biliary cirrhosis. Clin Exp Immunol. 1980 Oct;42(1):95–98. [PMC free article] [PubMed] [Google Scholar]
  3. Bernstein R. M., Neuberger J. M., Bunn C. C., Callender M. E., Hughes G. R., Williams R. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin Exp Immunol. 1984 Mar;55(3):553–560. [PMC free article] [PubMed] [Google Scholar]
  4. Bodenheimer H. C., Jr, Schaffner F., Sternlieb I., Klion F. M., Vernace S., Pezzullo J. A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis. Hepatology. 1985 Nov-Dec;5(6):1139–1142. doi: 10.1002/hep.1840050613. [DOI] [PubMed] [Google Scholar]
  5. Bodenheimer H., Jr, Schaffner F., Pezzullo J. Evaluation of colchicine therapy in primary biliary cirrhosis. Gastroenterology. 1988 Jul;95(1):124–129. doi: 10.1016/0016-5085(88)90300-9. [DOI] [PubMed] [Google Scholar]
  6. Briggs D. C., Donaldson P. T., Hayes P., Welsh K. I., Williams R., Neuberger J. M. A major histocompatibility complex class III allotype (C4B 2) associated with primary biliary cirrhosis (PBC). Tissue Antigens. 1987 Mar;29(3):141–145. doi: 10.1111/j.1399-0039.1987.tb01566.x. [DOI] [PubMed] [Google Scholar]
  7. Christensen E., Crowe J., Doniach D., Popper H., Ranek L., Rodés J., Tygstrup N., Williams R. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology. 1980 Feb;78(2):236–246. [PubMed] [Google Scholar]
  8. Christensen E., Neuberger J., Crowe J., Altman D. G., Popper H., Portmann B., Doniach D., Ranek L., Tygstrup N., Williams R. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology. 1985 Nov;89(5):1084–1091. doi: 10.1016/0016-5085(85)90213-6. [DOI] [PubMed] [Google Scholar]
  9. Clarke A. K., Galbraith R. M., Hamilton E. B., Williams R. Rheumatic disorders in primary biliary cirrhosis. Ann Rheum Dis. 1978 Feb;37(1):42–47. doi: 10.1136/ard.37.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Combes B. Prednisolone for primary biliary cirrhosis--good news, bad news. Hepatology. 1989 Oct;10(4):511–513. doi: 10.1002/hep.1840100418. [DOI] [PubMed] [Google Scholar]
  11. Crowe J. P., Christensen E., Butler J., Wheeler P., Doniach D., Keenan J., Williams R. Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterology. 1980 Jun;78(6):1437–1441. [PubMed] [Google Scholar]
  12. Crowe J. P., Molloy M. G., Wells I., Thompson B. R., Holborow E. J., Hamilton E., Williams R. Increased C1q binding and arthritis in primary biliary cirrhosis. Gut. 1980 May;21(5):418–422. doi: 10.1136/gut.21.5.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Crowe J., Christensen E., Doniach D., Popper H., Tygstrup N., Williams R. Early features of primary biliary cirrhosis: an analysis of 85 patients. Am J Gastroenterol. 1985 Jun;80(6):466–468. [PubMed] [Google Scholar]
  14. Dickson E. R., Grambsch P. M., Fleming T. R., Fisher L. D., Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology. 1989 Jul;10(1):1–7. doi: 10.1002/hep.1840100102. [DOI] [PubMed] [Google Scholar]
  15. Esquivel C. O., Van Thiel D. H., Demetris A. J., Bernardos A., Iwatsuki S., Markus B., Gordon R. D., Marsh J. W., Makowka L., Tzakis A. G. Transplantation for primary biliary cirrhosis. Gastroenterology. 1988 May;94(5 Pt 1):1207–1216. doi: 10.1016/0016-5085(88)90014-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hoofnagle J. H., Davis G. L., Schafer D. F., Peters M., Avigan M. I., Pappas S. C., Hanson R. G., Minuk G. Y., Dusheiko G. M., Campbell G. Randomized trial of chlorambucil for primary biliary cirrhosis. Gastroenterology. 1986 Dec;91(6):1327–1334. doi: 10.1016/0016-5085(86)90183-6. [DOI] [PubMed] [Google Scholar]
  17. James O. F. D-penicillamine for primary biliary cirrhosis. Gut. 1985 Feb;26(2):109–113. doi: 10.1136/gut.26.2.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. James O. F. Ursodeoxycholic acid treatment for chronic cholestatic liver disease. J Hepatol. 1990 Jul;11(1):5–8. doi: 10.1016/0168-8278(90)90263-q. [DOI] [PubMed] [Google Scholar]
  19. James O., Macklon A. F., Watson A. J. Primary biliary cirrhosis--a revised clinical spectrum. Lancet. 1981 Jun 13;1(8233):1278–1281. doi: 10.1016/s0140-6736(81)92457-0. [DOI] [PubMed] [Google Scholar]
  20. James S. P., Elson C. O., Jones E. A., Strober W. Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis. Gastroenterology. 1980 Aug;79(2):242–254. [PubMed] [Google Scholar]
  21. Jones E. A., Bergasa N. V. The pruritus of cholestasis: from bile acids to opiate agonists. Hepatology. 1990 May;11(5):884–887. doi: 10.1002/hep.1840110526. [DOI] [PubMed] [Google Scholar]
  22. Kaplan M. M., Alling D. W., Zimmerman H. J., Wolfe H. J., Sepersky R. A., Hirsch G. S., Elta G. H., Glick K. A., Eagen K. A. A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med. 1986 Dec 4;315(23):1448–1454. doi: 10.1056/NEJM198612043152304. [DOI] [PubMed] [Google Scholar]
  23. Kaplan M. M. Methotrexate treatment of chronic cholestatic liver diseases: friend or foe? Q J Med. 1989 Aug;72(268):757–761. [PubMed] [Google Scholar]
  24. Krams S. M., Dorshkind K., Gershwin M. E. Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice. J Exp Med. 1989 Dec 1;170(6):1919–1930. doi: 10.1084/jem.170.6.1919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lucey M. R., Neuberger J. M., Williams R. Primary biliary cirrhosis in men. Gut. 1986 Nov;27(11):1373–1376. doi: 10.1136/gut.27.11.1373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Markus B. H., Dickson E. R., Grambsch P. M., Fleming T. R., Mazzaferro V., Klintmalm G. B., Wiesner R. H., Van Thiel D. H., Starzl T. E. Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med. 1989 Jun 29;320(26):1709–1713. doi: 10.1056/NEJM198906293202602. [DOI] [PubMed] [Google Scholar]
  27. McFarlane I. G., Wojcicka B. M., Tsantoulas D. C., Portmann B. C., Eddleston A. L., Williams R. Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis, and other chronic liver diseases. Gastroenterology. 1979 Jun;76(6):1333–1340. [PubMed] [Google Scholar]
  28. Melia W. M., Johnson P. J., Neuberger J., Zaman S., Portmann B. C., Williams R. Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation. Gastroenterology. 1984 Sep;87(3):660–663. [PubMed] [Google Scholar]
  29. Meyers S., Walfish J. S., Sachar D. B., Greenstein A. J., Hill A. G., Janowitz H. D. Quality of life after surgery for Crohn's disease: a psychosocial survey. Gastroenterology. 1980 Jan;78(1):1–6. [PubMed] [Google Scholar]
  30. Minuk G. Y., Bohme C. E., Burgess E., Hershfield N. B., Kelly J. K., Shaffer E. A., Sutherland L. R., Van Rosendaal G. Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis. Gastroenterology. 1988 Nov;95(5):1356–1363. doi: 10.1016/0016-5085(88)90373-3. [DOI] [PubMed] [Google Scholar]
  31. Mitchison H. C., Bassendine M. F., Malcolm A. J., Watson A. J., Record C. O., James O. F. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss. Hepatology. 1989 Oct;10(4):420–429. doi: 10.1002/hep.1840100405. [DOI] [PubMed] [Google Scholar]
  32. Mitchison H. C., Lucey M. R., Kelly P. J., Neuberger J. M., Williams R., James O. F. Symptom development and prognosis in primary biliary cirrhosis: a study in two centers. Gastroenterology. 1990 Sep;99(3):778–784. doi: 10.1016/0016-5085(90)90968-7. [DOI] [PubMed] [Google Scholar]
  33. Murray-Lyon I. M., Thompson R. P., Ansell I. D., Williams R. Scleroderma and primary biliary cirrhosis. Br Med J. 1970 Aug 1;3(5717):258–259. doi: 10.1136/bmj.3.5717.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Neuberger J., Altman D. G., Christensen E., Tygstrup N., Williams R. Use of a prognostic index in evaluation of liver transplantation for primary biliary cirrhosis. Transplantation. 1986 Jun;41(6):713–716. doi: 10.1097/00007890-198606000-00009. [DOI] [PubMed] [Google Scholar]
  35. Neuberger J., Altman D. G., Polson R., Buckels J., Rolles K., Elias E., Calne R., McMaster P., Williams R. Prognosis after liver transplantation for primary biliary cirrhosis. Transplantation. 1989 Sep;48(3):444–447. doi: 10.1097/00007890-198909000-00019. [DOI] [PubMed] [Google Scholar]
  36. Neuberger J., Christensen E., Portmann B., Caballeria J., Rodes J., Ranek L., Tygstrup N., Williams R. Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis. Gut. 1985 Feb;26(2):114–119. doi: 10.1136/gut.26.2.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Neuberger J., Portmann B., Macdougall B. R., Calne R. Y., Williams R. Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med. 1982 Jan 7;306(1):1–4. doi: 10.1056/NEJM198201073060101. [DOI] [PubMed] [Google Scholar]
  38. Polson R. J., Portmann B., Neuberger J., Calne R. Y., Williams R. Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Clinical and histologic follow-up studies. Gastroenterology. 1989 Sep;97(3):715–725. doi: 10.1016/0016-5085(89)90643-4. [DOI] [PubMed] [Google Scholar]
  39. Portmann B., Popper H., Neuberger J., Williams R. Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients. Gastroenterology. 1985 Jun;88(6):1777–1790. doi: 10.1016/0016-5085(85)90001-0. [DOI] [PubMed] [Google Scholar]
  40. Poupon R., Chrétien Y., Poupon R. E., Ballet F., Calmus Y., Darnis F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet. 1987 Apr 11;1(8537):834–836. doi: 10.1016/s0140-6736(87)91610-2. [DOI] [PubMed] [Google Scholar]
  41. Roll J., Boyer J. L., Barry D., Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med. 1983 Jan 6;308(1):1–7. doi: 10.1056/NEJM198301063080101. [DOI] [PubMed] [Google Scholar]
  42. Routhier G., Epstein O., Janossy G., Thomas H. C., Sherlock, Kung P. C., Goldstein G. Effects of cyclosporin A on suppressor and inducer T lymphocytes in primary biliary cirrhosis. Lancet. 1980 Dec 6;2(8206):1223–1226. doi: 10.1016/s0140-6736(80)92481-2. [DOI] [PubMed] [Google Scholar]
  43. Smith M. G., Williams R., Doniach D., Calne R. Y. Effect of orthotopic liver transplantation on serum-autoantibodies. Lancet. 1971 Nov;2(7732):1006–1009. doi: 10.1016/s0140-6736(71)90325-4. [DOI] [PubMed] [Google Scholar]
  44. Stellon A. J., Davies A., Compston J., Williams R. Osteoporosis in chronic cholestatic liver disease. Q J Med. 1985 Nov;57(223):783–790. [PubMed] [Google Scholar]
  45. Stellon A. J., Webb A., Compston J., Williams R. Low bone turnover state in primary biliary cirrhosis. Hepatology. 1987 Jan-Feb;7(1):137–142. doi: 10.1002/hep.1840070127. [DOI] [PubMed] [Google Scholar]
  46. Stellon A. J., Williams R. Increased incidence of menstrual abnormalities and hysterectomy preceding primary biliary cirrhosis. Br Med J (Clin Res Ed) 1986 Aug 2;293(6542):297–298. doi: 10.1136/bmj.293.6542.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Warnes T. W., Smith A., Lee F. I., Haboubi N. Y., Johnson P. J., Hunt L. A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report. J Hepatol. 1987 Aug;5(1):1–7. doi: 10.1016/s0168-8278(87)80053-3. [DOI] [PubMed] [Google Scholar]
  48. Wiesner R. H., Ludwig J., Lindor K. D., Jorgensen R. A., Baldus W. P., Homburger H. A., Dickson E. R. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. N Engl J Med. 1990 May 17;322(20):1419–1424. doi: 10.1056/NEJM199005173222003. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES